This observation prompted us to knock down KMT2C expression in a wide panel of BC, COAD, HNSCC, and NSCLC cell lines which according to publicly available data showed variable KMT2C expression levels (Fig 4B). This evidence concerns the gene KMT2C and colon adenocarcinoma.